About this trial
The aim of this study is the systematic analysis of the development of perioperative rectal and urogenital function in patients undergoing rectal resection with total mesorectal excision and the identification of risk factors for urogenital and sphincter function loss after this procedure. Knowledge of the corresponding risk factors could enable the identification of patient cohorts that could benefit from an intensified or altered postoperative treatment path. The results of this study could thus significantly influence the clinical management of patients with rectal cancer and improve the functional outcome in the long term.
Eligibility criteria
Qualifiers
Patients undergoing rectal resection with total mesorectal excision
Disqualifiers
primary or secondary removal of rectal sphincter apparatus
patients with enterostomy persisting 12 months after initial rectal resection
Trial design
Treatments tested in this trial
- Rectal resection